Drugs / CAP
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01769066 Background | Dec 2009 → Feb 2014 | non-small cell lung carcinoma | Fudan University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CAP | “DDP IV 75mg/m2 ，DAY1 OR CAP IV AUC 5,DAY1 Gefitinib PO. 250mg DAY3-16” NCT01769066 ↗ |
| Route | Intravenous | “CAP IV AUC 5,DAY1” NCT01769066 ↗ |